A nationwide study across Ireland revealed that the vast majority of patients do not understand the core concepts underpinning a clinical trial.
Browsing: Taxonomy > Drug development
We spoke with a key study investigator of the multiple myeloma ENDEAVOR trial to explore the trial in more detail and to discover the potential clinical application of its overall survival findings.
Drugs used to treat heart and blood vessel problems have shown promise in combination with chemotherapy for acute myeloid leukemia treatment.
Researchers at Sanford Burnham Prebys Medical Discovery Institute (CA, USA) have published a study shedding new light on how the anti-cancer agent K-80003 (TX803) inhibits cancer cell growth.
As part of our recent Spotlight focus on biosimilars in oncology, we asked you to share your thoughts and opinions on the role of biosimilars in oncology. Thanks to all who shared your thoughts with us – the results have been translated into this summary infographic.
Listen to this exclusive interview with Peter Stern (University of Manchester, UK) to discover more about chemotherapy resistance in acute lymphoblastic leukemia and novel strategies to overcome it.
A group of researchers have uncovered a link between chemo-resistance in pediatric acute lymphoblastic leukaemia and the protein 5T4; early-testing indicates that targeting the protein could help improve treatment outcomes.